Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans
- PMID: 12183541
- PMCID: PMC128294
- DOI: 10.1128/IAI.70.9.4955-4960.2002
Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans
Abstract
The usefulness of isoniazid (INH), a key component of short-course chemotherapy of tuberculosis, is threatened by the emergence of drug-resistant strains of Mycobacterium tuberculosis with mutations in the katG gene. It is shown here that the most commonly occurring KatG mutation, where Ser 315 is replaced by Thr (S315T), is associated with clinically significant levels of INH resistance. In contrast to another resistant isolate, in which Pro replaces Thr 275, the S315T mutant produces active catalase-peroxidase and is virulent in the mouse model of the disease, indicating that a significant loss of bacterial fitness does not result from this frequent mutation. The implications of this finding for the transmission and reactivation of multidrug-resistant strains of M. tuberculosis are severe.
Figures
Similar articles
-
Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.J Biol Chem. 2003 Apr 25;278(17):14769-75. doi: 10.1074/jbc.M300326200. Epub 2003 Feb 13. J Biol Chem. 2003. PMID: 12586821
-
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.BMC Microbiol. 2018 Mar 22;18(1):22. doi: 10.1186/s12866-018-1168-x. BMC Microbiol. 2018. PMID: 29566660 Free PMC article.
-
Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.J Glob Antimicrob Resist. 2017 Dec;11:57-67. doi: 10.1016/j.jgar.2017.06.014. Epub 2017 Jul 23. J Glob Antimicrob Resist. 2017. PMID: 28743650
-
Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.Tuberculosis (Edinb). 2014 Dec;94(6):557-63. doi: 10.1016/j.tube.2014.08.011. Epub 2014 Sep 6. Tuberculosis (Edinb). 2014. PMID: 25270728 Review.
-
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.Infect Genet Evol. 2016 Nov;45:474-492. doi: 10.1016/j.meegid.2016.09.004. Epub 2016 Sep 6. Infect Genet Evol. 2016. PMID: 27612406 Review.
Cited by
-
Evolutionary Approaches to Combat Antibiotic Resistance: Opportunities and Challenges for Precision Medicine.Front Immunol. 2020 Aug 27;11:1938. doi: 10.3389/fimmu.2020.01938. eCollection 2020. Front Immunol. 2020. PMID: 32983122 Free PMC article. Review.
-
Evaluation of whole-genome sequence to predict drug resistance of nine anti-tuberculosis drugs and characterize resistance genes in clinical rifampicin-resistant Mycobacterium tuberculosis isolates from Ningbo, China.Front Public Health. 2022 Aug 18;10:956171. doi: 10.3389/fpubh.2022.956171. eCollection 2022. Front Public Health. 2022. PMID: 36062095 Free PMC article.
-
Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa.J Clin Microbiol. 2013 Oct;51(10):3277-85. doi: 10.1128/JCM.01122-13. Epub 2013 Jul 24. J Clin Microbiol. 2013. PMID: 23884993 Free PMC article.
-
Impact of isoniazid monoresistance on overall and vulnerable patient populations in Taiwan.Emerg Microbes Infect. 2024 Dec;13(1):2417855. doi: 10.1080/22221751.2024.2417855. Epub 2024 Oct 23. Emerg Microbes Infect. 2024. PMID: 39404086 Free PMC article.
-
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.Clin Microbiol Rev. 2006 Jul;19(3):558-70. doi: 10.1128/CMR.00060-05. Clin Microbiol Rev. 2006. PMID: 16847086 Free PMC article. Review.
References
-
- Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246. - PubMed
-
- Andersson, D. I., and B. R. Levin. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493. - PubMed
-
- Böttger, E. C., M. Springer, M. Pletschette, and P. Sander. 1998. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat. Med. 4:1343-1344. - PubMed
-
- Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B. G. Barrell, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
